Erick Lucera - Net Worth and Insider Trading

Erick Lucera Net Worth

The estimated net worth of Erick Lucera is at least $383,917 dollars as of 2024-11-06. Erick Lucera is the EVP, CHIEF FINANCIAL OFFICER of Editas Medicine Inc and owns about 116,829 shares of Editas Medicine Inc (EDIT) stock worth over $364,506. Erick Lucera is the Director of Beyond Air Inc and owns about 43,608 shares of Beyond Air Inc (XAIR) stock worth over $19,406. Erick Lucera is also the See Remarks of Valeritas Holdings Inc and owns about 225 shares of Valeritas Holdings Inc (VLRXQ) stock worth over $5. Details can be seen in Erick Lucera's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erick Lucera has not made any transactions after 2024-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Erick Lucera

To

Erick Lucera Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erick Lucera owns 6 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , Valeritas Holdings Inc (VLRXQ) , and Beyond Air Inc (XAIR) among others .

Click here to see the complete history of Erick Lucera’s form 4 insider trades.

Insider Ownership Summary of Erick Lucera

Ticker Comapny Transaction Date Type of Owner
AVEO AVEO Pharmaceuticals Inc 2020-01-06 Chief Financial Officer
VLRXQ Valeritas Holdings Inc 2019-03-07 See Remarks
XAIR Beyond Air Inc 2024-08-14 director
LIMIT LIMIT 2021-10-15 director
LIMIT LIMIT 2023-04-03 director
LIMIT LIMIT 2024-05-20 EVP & CHIEF FINANCIAL OFFICER

Erick Lucera Latest Holdings Summary

Erick Lucera currently owns a total of 3 stocks. Among these stocks, Erick Lucera owns 116,829 shares of Editas Medicine Inc (EDIT) as of May 20, 2024, with a value of $364,506 and a weighting of 94.94%. Erick Lucera owns 43,608 shares of Beyond Air Inc (XAIR) as of August 14, 2024, with a value of $19,406 and a weighting of 5.05%. Erick Lucera also owns 225 shares of Valeritas Holdings Inc (VLRXQ) as of May 22, 2017, with a value of $5 and a weighting of 0%.

Latest Holdings of Erick Lucera

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EDIT Editas Medicine Inc 2024-05-20 116,829 3.12 364,506
XAIR Beyond Air Inc 2024-08-14 43,608 0.45 19,406
VLRXQ Valeritas Holdings Inc 2017-05-22 225 0.02 5

Holding Weightings of Erick Lucera


Erick Lucera Form 4 Trading Tracker

According to the SEC Form 4 filings, Erick Lucera has made a total of 1 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Editas Medicine Inc is the sale of 22,337 shares on May 20, 2024, which brought Erick Lucera around $125,311.

According to the SEC Form 4 filings, Erick Lucera has made a total of 2 transactions in Beyond Air Inc (XAIR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Beyond Air Inc is the acquisition of 39,266 shares on August 14, 2024, which cost Erick Lucera around $15,706.

According to the SEC Form 4 filings, Erick Lucera has made a total of 0 transactions in Valeritas Holdings Inc (VLRXQ) over the past 5 years. The most-recent trade in Valeritas Holdings Inc is the acquisition of 75 shares on May 22, 2017, which cost Erick Lucera around $7,425.

Insider Trading History of Erick Lucera

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Erick Lucera Trading Performance

GuruFocus tracks the stock performance after each of Erick Lucera's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erick Lucera is -22.39%. GuruFocus also compares Erick Lucera's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erick Lucera within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Erick Lucera's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Erick Lucera

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.19 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.55 LIMIT LIMIT LIMIT LIMIT LIMIT

Erick Lucera Ownership Network

Ownership Network List of Erick Lucera

No Data

Ownership Network Relation of Erick Lucera

Insider Network Chart

Erick Lucera Owned Company Details

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Erick Lucera is the Chief Financial Officer of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

Erick Lucera Mailing Address

Above is the net worth, insider trading, and ownership report for Erick Lucera. You might contact Erick Lucera via mailing address: 138 Thistle Road, North Andover Ma 08145.